Our team is excited to join the global research community at the Tau Global Conference 2026! With over 5,000 clinical trials supported across therapeutic areas, our experts at Headlands Research are dedicated to advancing new treatments for tauopathies.
Interested in working with clinical sites experienced in tau and neurodegenerative disease research? Connect with our Headlands team to schedule a meeting at the Tau Global Conference 2026:
- Dr. Mark A. Goldstein, Founder, former President and Medical Director, and current Principal Investigator and Senior Advisor, Neuroscience at Headlands Research JEM
- Belinda Russell, Director of CNS Excellence